Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Flack

Showing results (151-160 of 263) with videos related to

Pageof 27
Sort By:
Managed Care Interface|November 27, 2002
Cardiovascular disease costs associated with uncontrolled hypertensionJohn M Flack, Roman Casciano, Julian Casciano, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|December 1, 1995
Epidemiology of minority healthJ M Flack, H Amaro, W Jenkins, et al.
Hypertension (Dallas, Tex. : 1979)|June 24, 2023
Editors' Commentary on the 2023 ESH Management of Arterial Hypertension GuidelinesPaul K Whelton, John M Flack, Garry Jennings, et al.
The American Journal of Cardiology|January 7, 1998
Effects and tolerability of irbesartan versus enalapril in patients with severe hypertension. Irbesartan Multicenter InvestigatorsP Larochelle, J M Flack, T C Marbury, et al.
Hypertension (Dallas, Tex. : 1979)|August 24, 2005
A noninferiority comparison of valsartan/hydrochlorothiazide combination versus amlodipine in black hypertensivesMatthew R Weir, Keith C Ferdinand, John M Flack, et al.
Archives of Internal Medicine|June 29, 2000
The rapidity of drug dose escalation influences blood pressure response and adverse effects burden in patients with hypertension: the Quinapril Titration Interval Management Evaluation (ATIME) Study. ATIME Research GroupJ M Flack, C Yunis, J Preisser, et al.
Hypertension (Dallas, Tex. : 1979)|March 5, 2014
Clinical effect of naturally random allocation to lower systolic blood pressure beginning before the development of hypertensionBrian A Ference, Stevo Julius, Nitin Mahajan, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|April 24, 2015
Safety and efficacy of antihypertensive prescription at emergency department dischargeAaron Brody, Tahsin Rahman, Brian Reed, et al.
Journal of the American Society of Hypertension : JASH|November 6, 2018
Predicting the risk of apparent treatment-resistant hypertension: a longitudinal, cohort study in an urban hypertension referral clinicMichael G Buhnerkempe, Albert Botchway, Carlos E Nolasco Morales, et al.
Journal of Community Hospital Internal Medicine Perspectives|March 11, 2026
Slipping Through the Chasm of Multicenter Hand-offs-Rare Incidence of Nintedanib Induced Renal Failure: Case ReportMuhammad Mohsin Abid, Muhammad Ijaz Khan, Tanvi Jain, et al.
Pageof 27

Showing results (151-160 of 263) with videos related to

Sort By:
Pageof 27
Managed Care Interface|November 27, 2002
Cardiovascular disease costs associated with uncontrolled hypertensionJohn M Flack, Roman Casciano, Julian Casciano, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|December 1, 1995
Epidemiology of minority healthJ M Flack, H Amaro, W Jenkins, et al.
Hypertension (Dallas, Tex. : 1979)|June 24, 2023
Editors' Commentary on the 2023 ESH Management of Arterial Hypertension GuidelinesPaul K Whelton, John M Flack, Garry Jennings, et al.
The American Journal of Cardiology|January 7, 1998
Effects and tolerability of irbesartan versus enalapril in patients with severe hypertension. Irbesartan Multicenter InvestigatorsP Larochelle, J M Flack, T C Marbury, et al.
Hypertension (Dallas, Tex. : 1979)|August 24, 2005
A noninferiority comparison of valsartan/hydrochlorothiazide combination versus amlodipine in black hypertensivesMatthew R Weir, Keith C Ferdinand, John M Flack, et al.
Archives of Internal Medicine|June 29, 2000
The rapidity of drug dose escalation influences blood pressure response and adverse effects burden in patients with hypertension: the Quinapril Titration Interval Management Evaluation (ATIME) Study. ATIME Research GroupJ M Flack, C Yunis, J Preisser, et al.
Hypertension (Dallas, Tex. : 1979)|March 5, 2014
Clinical effect of naturally random allocation to lower systolic blood pressure beginning before the development of hypertensionBrian A Ference, Stevo Julius, Nitin Mahajan, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|April 24, 2015
Safety and efficacy of antihypertensive prescription at emergency department dischargeAaron Brody, Tahsin Rahman, Brian Reed, et al.
Journal of the American Society of Hypertension : JASH|November 6, 2018
Predicting the risk of apparent treatment-resistant hypertension: a longitudinal, cohort study in an urban hypertension referral clinicMichael G Buhnerkempe, Albert Botchway, Carlos E Nolasco Morales, et al.
Journal of Community Hospital Internal Medicine Perspectives|March 11, 2026
Slipping Through the Chasm of Multicenter Hand-offs-Rare Incidence of Nintedanib Induced Renal Failure: Case ReportMuhammad Mohsin Abid, Muhammad Ijaz Khan, Tanvi Jain, et al.
Pageof 27